Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of high pressure-based instruments, consumables, and related services for the global life sciences industry, this morning announced the commercial launch of its Biopharmaceuticals Contract Services Business. The eagerly-anticipated launch … Continue reading →

Pressure BioSciences (OTCQB: PBIO) today announced that a Centre for the Proteome of Human Cancer (“ProCan”) scientific team has published a recommended sample preparation protocol built around PBIO’s Barocycler instrument system, which is designed to improve diagnosis and treatment of … Continue reading →

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform solutions, recently named Dr. Bradford A. Young as its senior vice president and chief commercial officer. An article discussing the company’s … Continue reading →

Pressure BioSciences Inc. (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform solutions, this morning announced that President and CEO Richard T. Schumacher was recently interviewed by broadcast journalist Christine Corrado of … Continue reading →

Pressure BioSciences Inc. (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform solutions to the worldwide life sciences industry, this morning announced the featured interview of its president and CEO Richard T. … Continue reading →

Pressure BioSciences Inc. (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform solutions to the worldwide life sciences industry, late Wednesday announced its financial results for the third quarter and year-to-date periods … Continue reading →

Pressure BioSciences Inc. (OTCQB: PBIO) this morning announced that it will host a teleconference to discuss the company’s Q3 2018 financial results and provide a business update. Interested parties may attend the call, scheduled for November 14, 2018, at 4:30 … Continue reading →

Pressure BioSciences (OTCQB: PBIO) today announced that significant progress has been made in its development program for its proprietary Ultra Shear Technology (“UST”) platform. Per the update, the company has completed development of the first working prototype of its UST … Continue reading →

Pressure BioSciences (OTCQB: PBIO) today announced appointment of its Sr. Vice President and Chief Commercial Officer Dr. Bradford A. Young, effective Monday, November 5, 2018. In this new key position, Dr. Young’s responsibilities will include assessing multiple major opportunities in … Continue reading →

Pressure BioSciences (OTCQB: PBIO) (“PBI”) today unveiled its intention to further commit substantial financial and operational support to fast-track the development of its Ultra Shear Technology (“UST”) platform, effective immediately. The company plans to pursue commercialization of its technology platform … Continue reading →